- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03812458
GASA-CIR Trail (Guidance and the Symptoms of Acute Stress and Anxiety in Critically Ill Patients Relatives in Intensive Care Unit) (GASA-CIR)
Impact of the Guidance, Through Website and Brochure, in the Symptoms of Acute Stress and Anxiety in Relatives of Critically Ill Paciente in Intensive Care Unit: Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The hospitalization of one family member may be responsible for the generation of anxiety and depression, especially if the patient environment for the intensive care unit (ICU). The orientation of family members, through website and brochure, seems to have effect of reducing these symptoms, however, there is a shortage of studies capable of such conduct. The focus of this study will be to evaluate the impact of family guidance in reducing symptoms of depression, acute stress and anxiety displayed by them, in addition to verifying the association between resilience.
A randomized clinical trial 1:1 among relatives of patients admitted to an intensive care unit, the randomization will be in blocks of different sizes and stratified according to the educational level of the familiar. Intervention group will be composed by family members who receive a printed brochure and will be encouraged to visit a website detailed information and plain language about the ICU environment (treatments, care, alarms, multidisciplinary team) and the critically ill patient characteristics (organic dysfunction, prognosis, palliative care, organ dysfunction). The family, of the control group, will not receive the printed brochure and are not encouraged to visit the website. After hospitalization of the patient in the ICU, the research team will have up to 48 hrs to evaluate the eligibility criteria of the next of kin of this patient. Primary outcome will be the impact of orientations on symptoms of post-traumatic stress, assessed by the IES-R scale. Secondary outcome measures will include symptoms of anxiety and depression at the end of 7 days and after 3 months of follow-up by the HADS scale, the degree of satisfaction of the relatives, through the FS-ICU scale, as well as the association of resilience, through the CD-RISC scale, with the symptoms of anxiety and depression The study will occur with families of patients admitted to the ICUs of Hospital Moinhos de Vento and Hospital Ernesto Dornelles. We will collect characteristics related to demographic, social, educational features, levels of resilience, religiosity and prior history of mood disorder, anxiety disorder or post-traumatic stress disorder, length of ICU stay, SAPS III, and ICU and hospital outcomes.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Vitória Homem Machado
- Phone Number: 55 51 991022093
- Email: vitoriahomemmachado@gmail.com
Study Contact Backup
- Name: Hospital Moinhos de Vento - ICU
- Phone Number: 55 51 33143434
Study Locations
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brazil, 90035902
- Recruiting
- Hospital Moinhos de Vento
-
Contact:
- Vitoria Machado
- Email: vitoriahomemmachado@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- For patient, with more than 18 years old, who ICU admission exceeding 48 hours;
- For Patient's Family Members: familiar close to a patient hospitalized in the ICU (spouse, father, mother, son, daughter, grandmother, brother, sister, uncle, aunt, cousin);
Exclusion Criteria:
- For Patient's Family Members: communication difficulty (illiteracy, not speaking Portuguese, deafness or mutism). Some other family member of the patient has already been included in the study. Refusal to sign the term of free and clarified consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Guidance
The intervention group will consist of the relatives who will receive a printed brochure and are encouraged to visit a website with detailed information and with simple language regarding the ICU environment (treatments, care, alarms, multidisciplinary team) and the characteristics of critically ill patients (organ dysfunction, prognosis, palliative care, organ dysfunction).
|
website and brochure
|
No Intervention: Control
The families who will not receive the brochure and are not encouraged to visit the website.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acute stress in critically ill relatives.
Time Frame: After 7 days from enrollment in ICU.
|
Using the Impact of Events Scale-Revised.
The scale contains 22 questions.
It evaluates the subjective distress caused by traumatic events.
Items are rated on a 5-point scale, ranging from 0 (nothing) to 4 (extremely).
The total score ranges from 0 to 88.
A score greater than 33 identifies individuals with symptoms of acute stress disorder.
|
After 7 days from enrollment in ICU.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction of the relatives of patients admitted to the ICU: FS-ICU scale
Time Frame: After 7 days from enrollment in ICU.
|
Using the FS-ICU scale.
The Family Satisfaction in the Intensive Care Unit (FS-ICU) questionnaire measures family satisfaction with care in the intensive care unit.
The score ranges 0-100, with higher scores indicating greater satisfaction.
|
After 7 days from enrollment in ICU.
|
Symptoms of post-traumatic stress.
Time Frame: 3 months from enrollment in ICU.
|
Assessed by the Impact of Events Scale-Revised (IES-R).
The scale contains 22 questions.
It evaluates the subjective distress caused by traumatic events.
Items are rated on a 5-point scale, ranging from 0 (nothing) to 4 (extremely).
The total score ranges from 0 to 88.
A score greater than 33 identifies individuals with symptoms of acute stress disorder.
|
3 months from enrollment in ICU.
|
Symptoms of anxiety and depression
Time Frame: 3 months from enrollment in ICU.
|
Using the HADS scale.
The questionnaire is composed of 14 questions.
The total score ranges from 0 to 42.
Score greater than 8 in subgroup, or a total score greater than 16, identify patients with anxiety and depression symptoms.
|
3 months from enrollment in ICU.
|
Symptoms of anxiety and depression
Time Frame: After 7 days from enrollment in ICU.
|
Using the HADS scale.
The questionnaire is composed of 14 questions.
The total score ranges from 0 to 42.
Score greater than 8 in subgroup, or a total score greater than 16, identify patients with anxiety and depression symptoms.
|
After 7 days from enrollment in ICU.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- acute stress,anxiety
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on website and brochure
-
University of MilanCatholic University of the Sacred Heart; Societa Italiana Anestesia Analgesia... and other collaboratorsUnknownCritical Illness | Stress Disorders, Post-Traumatic | Stress Disorders, Traumatic, AcuteItaly
-
St. Jude Children's Research HospitalCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant NeoplasmUnited States
-
NYU Langone HealthCompleted
-
Center for Primary Care and Public Health (Unisante)...Active, not recruiting
-
Centre hospitalier de l'Université de Montréal...Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials NetworkCompleted
-
University of Illinois at ChicagoTerminatedHead and Neck CancerUnited States
-
IRCSS Istituto Dermopatico dell'Immacolata, Fondazione...Ministry of Health, Italy; Centro di Eccellenza per la Cultura e la Ricerca...Completed
-
Fox Chase Cancer CenterKnowledge NetworksCompleted